NCT04704427

Brief Summary

In order to explore the role and expound the mechanism of rehabilitative brain computer interface (BCI)-based training (referred to as the Walk Again Neurorehabilitation protocol) in neurofunctional reconstruction in acute phase of cerebral infarction, the investigators choose non-invasive BCI to study lower limb function of patients with acute cerebral infarction. The investigators evaluate lower limb function, the influence on the central brain functional network and relevant immuno-inflammatory indicators, so that the investigators can explore the therapeutic effect and mechanism in the acute phase of cerebral infarction and provide theoretical bases and feasible guidances for the treatment of post-stroke dyskinesia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 11, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

January 16, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2021

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

January 11, 2021

Status Verified

December 1, 2020

Enrollment Period

11 months

First QC Date

December 20, 2020

Last Update Submit

January 8, 2021

Conditions

Keywords

Brain Computer InterfaceLower Limb Function RecoveryBrain Machine Interface

Outcome Measures

Primary Outcomes (1)

  • Change in Fugl-Meyer score of lower limbs from baseline to 4 weeks.

    It consists of 17 individual assessments that are summed to generate a total score. Scores range from 0-34, the higher the better.

    0-4 weeks.

Secondary Outcomes (9)

  • Functional ambulation category scale

    4 weeks and 90 days.

  • 10-meter walk test

    4 weeks and 90 days.

  • Modified Barthel index

    4 weeks and 90 days.

  • National Institutes of Health Stroke Scale

    4 weeks and 90 days.

  • Gait analysis ( stride frequency, step length and velocity)

    4 weeks and 90 days.

  • +4 more secondary outcomes

Study Arms (2)

Rehabilitative BCI training

EXPERIMENTAL

The experimental group will receive brain computer interface-based lower limb function training (BCI-LLT), 30 minutes/time, 5 times/week, with a 4-week training period.. The training using the lower limb orthosis targeted the patient's ability to walk.

Device: Non-invasive BCI training

Traditional physical therapy protocol

ACTIVE COMPARATOR

The control group will only receive traditional physical therapy protocol. The traditional physical therapy protocol of lower limb conducted with the same treatment frequency, intensity and duration of treatment, including muscle strength training, balance training and walking training, etc.

Other: Traditional Physiotherapy protocol

Interventions

In the experimental group, the participants receive non-invasive rehabilitative BCI training. The training using the lower limb orthosis targeted the patient's ability to walk.

Rehabilitative BCI training

In the control group,the participants receive the traditional physiotherapy protocol, including muscle strength training, balance training and walking training, etc.

Traditional physical therapy protocol

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The diagnosis of cerebral infarction conforms to the diagnostic criteria of "Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018".
  • ≤ age ≤ 60 .
  • Onset (last-seen-well) time to randomization time from 24-72 hours.
  • First onset.
  • The lesion is assessed by MRI as a single subcortical infarction of the anterior circulation.
  • ≤NIHSS≤15 (and 1 ≤6a/b≤3 ).
  • ≤FAC functional walking scale score ≤ 3.
  • Signed informed consent from subject or legally authorized representative.

You may not qualify if:

  • Unstable vital signs.
  • Progressive stroke.
  • Patients have received intravenous thrombolysis or endovascular treatment.
  • Cardiogenic cerebral embolism.
  • Presence of moderate or higher vascular stenosis or vulnerable plaque based on Imaging assessment.
  • With other diseases of the nervous system.
  • With serious diseases of other systems (severe circulatory system, respiratory system, motor system) and other diseases unsuitable for training, such as atrial fibrillation, heart failure, lung infection, severe liver or kidney insufficiency, lower extremity venous thrombosis.
  • Lower limb dysfunction caused by other reasons, such as fracture, lower limb deformity, etc.
  • With contraindications in imaging examinations, such as metal implantation, fear of claustrophobia, and severe obesity.
  • Patient who cannot cooperate with training, such as mental disorders, cognitive dysfunction, Mini-Mental State Examination (MMSE) \<21 points, etc.
  • Other reasons: alcoholism; pregnancy; skull defect; indwelling urinary catheter; vision defects affect training, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Jackson A, Zimmermann JB. Neural interfaces for the brain and spinal cord--restoring motor function. Nat Rev Neurol. 2012 Dec;8(12):690-9. doi: 10.1038/nrneurol.2012.219. Epub 2012 Nov 13.

    PMID: 23147846BACKGROUND
  • Ramos-Murguialday A, Broetz D, Rea M, Laer L, Yilmaz O, Brasil FL, Liberati G, Curado MR, Garcia-Cossio E, Vyziotis A, Cho W, Agostini M, Soares E, Soekadar S, Caria A, Cohen LG, Birbaumer N. Brain-machine interface in chronic stroke rehabilitation: a controlled study. Ann Neurol. 2013 Jul;74(1):100-8. doi: 10.1002/ana.23879. Epub 2013 Aug 7.

    PMID: 23494615BACKGROUND
  • Lopez-Larraz E, Sarasola-Sanz A, Irastorza-Landa N, Birbaumer N, Ramos-Murguialday A. Brain-machine interfaces for rehabilitation in stroke: A review. NeuroRehabilitation. 2018;43(1):77-97. doi: 10.3233/NRE-172394.

    PMID: 30056435BACKGROUND
  • Chaudhary U, Birbaumer N, Ramos-Murguialday A. Brain-computer interfaces for communication and rehabilitation. Nat Rev Neurol. 2016 Sep;12(9):513-25. doi: 10.1038/nrneurol.2016.113. Epub 2016 Aug 19.

    PMID: 27539560BACKGROUND
  • Lebedev MA, Nicolelis MA. Brain-Machine Interfaces: From Basic Science to Neuroprostheses and Neurorehabilitation. Physiol Rev. 2017 Apr;97(2):767-837. doi: 10.1152/physrev.00027.2016.

    PMID: 28275048BACKGROUND
  • Donati AR, Shokur S, Morya E, Campos DS, Moioli RC, Gitti CM, Augusto PB, Tripodi S, Pires CG, Pereira GA, Brasil FL, Gallo S, Lin AA, Takigami AK, Aratanha MA, Joshi S, Bleuler H, Cheng G, Rudolph A, Nicolelis MA. Long-Term Training with a Brain-Machine Interface-Based Gait Protocol Induces Partial Neurological Recovery in Paraplegic Patients. Sci Rep. 2016 Aug 11;6:30383. doi: 10.1038/srep30383.

    PMID: 27513629BACKGROUND
  • Selfslagh A, Shokur S, Campos DSF, Donati ARC, Almeida S, Yamauti SY, Coelho DB, Bouri M, Nicolelis MAL. Non-invasive, Brain-controlled Functional Electrical Stimulation for Locomotion Rehabilitation in Individuals with Paraplegia. Sci Rep. 2019 May 1;9(1):6782. doi: 10.1038/s41598-019-43041-9.

    PMID: 31043637BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Guoguang Zhao

    Xuanwu Hospital, Beijing

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Junwei Hao, MD,PHD

CONTACT

Haijie Liu, MD,PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2020

First Posted

January 11, 2021

Study Start

January 16, 2021

Primary Completion

December 25, 2021

Study Completion

December 31, 2021

Last Updated

January 11, 2021

Record last verified: 2020-12